Acute Oncology Pathway Board Meeting Minutes

Manchester Cancer
ACUTE ONCOLOGY PATHWAY BOARD MEETING
Minutes of the meeting held on 25th July 2014, 2-4pm, at The Christie
IN ATTENDANCE
Claire Mitchell
Christine Griffiths
Sarah Wilks
Melanie Dadkhah-Taeidy
Jo Humphreys
Anne Allen
Paula Hall
Vanya Walmsley
Barbara Hefferon
Catherine Coyle
Elena Takenchi
Carol Diver
Antony McGurk
Conor Fitzpatrick
Caroline McCall
CHAIR, Consultant Medical Onc.
AO ANP, Stockport
Acute Oncology CNS, CMFT
AOS CNS, Tameside
AOS CNS, UHSM
AOS CNS, Macclesfield
AO Senior Nurse, Christie
AOS CNS, Bolton
AO CNS, Wigan
Consultant Clinical Oncology / AO lead SHH
Consultant Medical Oncology / AO lead Wigan
Lead Cancer Nurse, Tameside
Clinical Audit Facilitator, Christie
Therapy Radiographer, Christie
Acute Oncology Pathway Manager
Agenda Item
1. Apologies
Apologies were noted from: Yvonne Summers, Vicki Tyrell, Anne Davies,
Sarah Taylor
2. Minutes of last meeting:
Consultant Microbiologist Kirsty Dodgson has been contacted to see if
progress has been made in relation to network agreement of microbiology
consensus of neutropenic sepsis antibiotic policy. Feedback awaited.
3. Mortality audit data collection:
Presentation from Anthony McGurk regarding 30day SACT mortality audits.
Teams asked for breakdown of data relating to treatment intent ie adjuvant
vs palliative
4. Terms of Reference
Terms of reference and constitution agreed by pathway board
Action
CM to re-contact
for update
AMcG to provide
data
CM / CMcC to
upload onto MC
website
5. Introduction to Manchester Cancer presentation:
Caroline McCall presented overview of role of Manchester Cancer
6. Team updates/Funding non-surgical oncologist
-
Bolton – agreed funding – post advertised and appointed
CM to continue to
liase with Chrsitie
Manchester Cancer
-
Pennine – agreed; ongoing discussions between the Christie and PAT in regards on going
relation to posts
AO appointments
Tameside – agreed; ongoing discussions between the Christie and
Tameside in relation to posts
Leighton – Consultant (Laura Horsley in post), 2 AO sessions per week
Wigan – 2nd Consultant now in post – number of AO sessions currently
being determined
Most sites remain non-peer review compliant as NSO posts do not provide 5 day
cover and some sites continue to have a single nurse led service



Peer Review
-Remains unclear what future measures will be in place. National meeting in
Birmingham highlighted issues with current measures.
- Measures relating to fast track clinics difficult to comply with due to
structure of cancer services
- No site currently peer review compliant
Sub-group Feedback:
MSCC :
MSCC co-ordinator, Conor Fitzpatrick –service continues to be busy, people
using service well.
Stats equal to national data
Referred through hotline team out of hours - Christie still funding hotline
Need to highlight to provider board funding issues in relation to MSCC –
incorporates MSCC co-ordinator plus Spinal Co-ordinator at Salford – Rachel
Potts. Both post as package as MSCC package.
Next MSCC meeting date to be confirmed
CF to confirm next
MSCC meeting
date.
CM to highlight to
Manchester Cancer
Director ongoing
funding issues
through annual
report.

CUP – provisional network guideline completed – to be sent out to
appropriate pathway groups for comments.
CM to send out to
appropriate
pathway boards.

Education – meeting held prior to pathway board meeting.
Conor Fitzpatrick to lead group and liase with relevant parties including
Christie and Shool of Oncology
CF to feedback at
next meeting

Nurses forum – successful first meeting
Would like speaker for each meeting.
Next meeting scheduled for August
KH to feedback at
next meeting
7. Neutropenic Sepsis Audits:
Teams given opportunity to present neutropenic sepsis audits
No teams currently have data to present therefore opportunity to present at next
meeting board meeting will be given
CMcC to put on
agenda for next
pathway meeting
8. AO Service Specification :
Service specification drafted by CM has been agreed and approved by the acute
CM / CMcC to
upload service
2
Manchester Cancer
oncology pathway board.
Agreed that the aim of AO services should be full peer review compliance and the
clinical model of 2 x nurses per team plus 2 NSO’s providing x 5 PA’s of clinical
cover should be supported by the pathway board.
The service specification should be MC banded to provide leverage for further
funding of posts.
specification and
distribute to
provider board via
annual report
9. SVCO Pathway – the teams present did not feel that there was a need for a
network co-ordinated pathway for SVCO as local trust had their own policies which
were felt to be effective.
Clinical guidelines for SVCO to be Manchester Cancer “branded” and placed on
website
CM to review
network guidelines
and upload to MC
website
10. AOB
AO Service expansion:
 7 day working – Gold Standard. Future expansion of services should reflect
this aim
 Community expansion – options:
o AO in community but this may not be optimal use of resources.
o AO nurse led rapid access clinics at Christie satellite centres /mobile
unit
 Rapid access clinic to commence at Christie Sept 2014 – review this model as
a pilot ? could be rolled out to other Christie sites
 Christie Hotline – ongoing funding
PH to feedback re
Christie clinic
model
To liaise with
Louise Lawrence
AO project lead at
Christie
Research :
No current research specific to acute oncology, however CUP One trial is recruiting
and patients are being approached and recruited for this.
Commissioning:
It would be useful to know what outcomes commissioners would like to see for
outcomes relating to AO – in order to refine data collection
DATE OF NEXT MEETING ……………………………………………………
3
CMcC to liaise with
cancer care
commissioners
regards outcomes
measures

Download Report